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Abstract: Fumonisins are mycotoxins produced by Fusarium verticillioides, a filamentous fungus that
is a widespread pathogen of corn. The biosynthesis of fumonisins is catalyzed by an iterative modular
polyketide synthase (PKS). The study of the biosynthetic mechanism for these reduced fungal polyketides
has been challenging due to the difficulties in detecting the intermediates with a linear carbon chain and
manipulating the 7-domain PKS gene from the filamentous fungus. Here, we described the development of
a genetic system for functionally manipulating the methyltransferase domain of FUM1 that is responsible
for the assembly of a dimethylated 18-carbon chain. Using a two-stage screening strategy, including both
positive and negative screenings, we were able to generate mutant strains with a specifically changed
active-site in FUM1. LC-MS analyses indicated that biosynthetic intermediates were detectable in the
early stage of culture. The results represent the first functional manipulation of the PKS involved in the
biosynthesis of fumonisins.
Keywords: Fumonisin, Polyketide synthase, Mycotoxin, Fusarium verticillioides

1 Introduction

Polyketides are biosynthesized through sequential decarboxylative condensations of short carboxylic acids, which is
catalyzed by polyketide synthases (PKSs) [8]. Recently, several genomes of filamentous fungi have been sequenced. The
sequencing data revealed a large number of putative PKS
genes existing in filamentous fungi [9]. These fungal PKS
genes outnumber those found in the genomes of Streptomyces
avermitilis[10] and Streptomyces coelicolor[11], actinomycete species that are traditionally regarded as the most abundant source for polyketide metabolites. Fungal PKSs are clas-

Filamentous fungi are rich sources for polyketide metabolites, some of which have important biological activities
[1]. Among them, fumonisins are a group of mycotoxins
produced by Fusarium verticillioides, which cause several fatal animal diseases, including leukoencephalomalacia
in horses [2, 3], pulmonary edema in swine [4], and cancer in rats [5]. In addition, fumonisins are associated with
human esophageal cancer [6, 7].
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sified into three groups: (i) PKSs for single aromatic ring; (ii)
PKSs for polycyclic aromatic ring; and (iii) PKSs for reduced
complex-polyketides [12, 13]. They are defined as iterative
type I PKSs because they usually contain only a single set of
domains, in contrast to the non-iterative modular type I PKSs
and monofunctional type II PKSs found in bacteria [1]. Typically, a module consists of a β-ketoacyl synthase (KS), an acyltransferase (AT), and an acyl carrier protein (ACP). Many
PKSs, especially those for reduced polyketides, also contain
additional domains, such as β-ketoacyl reductase (KR), dehydratase (DH), enoylreductase (ER), and methyltransferase
(MT) (Fig. 1). A single-modular PKS can catalyze multiple
cycles of chain elongation [1, 14].
Although information for the biosynthetic mechanism
for aromatic fungal polyketides has begun to emerge in
the recent years [15–22], the mechanism for the reduced
polyketides remains unknown. Two major difficulties are associated with the studies of the reduced fungal polyketides.
One is due to the structural feature of the metabolites,
which often have a linear carbon backbone resembling fatty acids. This feature not only makes their detection difficult but also often leads to no intermediates accumulated
in the gene-disruption mutants because the putative precursors could be utilized by other pathways. Another difficulty
is related to the genetic manipulation of the multi-domain
genes in filamentous fungi. The PKS genes responsible for
the biosynthesis of reduced fungal polyketides are more
complex than those for aromatic polyketides. For example,
FUM1 responsible for assembling the 18-carbon chain of
fumonisins in F. verticillioides was predicted to code seven domains, KS–AT–DH–MT–ER–KR–ACP (Fig. 1) [23].
The gene-disruption approach, most commonly through
inserting a selection marker, such as hygromycin [23, 24]
or a phleomycin [25] resistance gene into the target gene,
has been performed to study this group of PKSs. However,
this type of manipulations could only provide evidence for
the relatedness of the PKS gene to the biosynthesis of the
metabolite. In this study, our goal was to develop a genetic system for functionally manipulating the individual domains of the fungal PKS for reduced polyketides. Reported
here are results obtained from an active-site point mutation
of the methyltransferase domain of FUM1.
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2 Materials and methods
2.1 Strains and culture media
F. verticillioides wild-type strain A0149 (FGSC number
7600) was provided by Dr. David Gilchrist (University of
California, Davis). YPD medium and V-8 juice agar were
used to produce mycelia and conidia [23], and cracked
maize kernels (CMK) for fumonisin production [23, 26].
2.2 DNA manipulation and construction of plasmids
Escherichia coli DH5-α strain was used as the host for
general DNA preparation, and the pGEM-zf series from Promega (Madison, WI) for cloning and DNA sequencing. Plasmid preparation and DNA extraction were carried out with
Qiagen kits (Valencia, CA), and all other manipulations were
carried out according to standard methods [27]. To introduce
site directed mutagenesis at the S-adenosylmethionine (SAM)
binding site of the FUM1 MT domain, pUCHΔmt was constructed by means of SOE (splicing by overlap extension)
[28], involving three PCR amplifications. The first PCR was
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carried out with Cos6B as template [23], using primers MT1
and MT2 (Table 1). The 1187-bp product (mt1) contained a
point mutation introduced by the MT2 primer, in which the
original sequence, 5’-GGCACC-3’, in the SAM binding motif
of the MT domain was changed to 5’-AAGCTT-3’ (Gly1470–
Thr1471 of Fum1p changed to Lys1470–Leu1471). This change
also created a Hin dIII site to facilitate the mutant identification in the later stage. The second PCR was similarly carried
out using primers MT3 and MT4 to produce a 1185-bp product (mt2). The third PCR used the mixture of mt1 and mt2 as
templates and MT1 and MT4 as primers to get the final 2352bp product. The fragment was digested with Eco RI/Kpn I
and cloned into the same sites of pT7Blue–3 (Novagen) for
sequencing and further into Sal I/Kpn I sites of pUCH2-8
[23] to yield pUCHΔmt. This construct contains an E. coli
hygromycin B resistance gene (Hyg B) fused to the Promoter
1 from C. heterostrophus[29] (Fig. 2).

Southern analysis to identify the gene disruption mutants.
In the second stage, the mutants were selected for the loss
of hygromycin B resistance. Single conidia-derived cultures were allowed to grow in 250-ml Erlenmeyer flasks
containing 50 ml liquid YPD medium without hygromycin
B. After five-day growth, a 50-μl of the culture was transferred to a 50-ml fresh liquid YPD medium. The transfer process was repeated every five days. After 4–5 serial transfers, the culture was serial-diluted and spread on
YPD plate to produce single colonies. The individual single colonies were then replica-plated on two YPD plates,
one with hygromycin B and one without. After two-day
growth, colonies that did not grow on the plate with hygromycin B but grew on the plate without hygromycin B
were selected as putative gene replacement mutants.

2.3 Transformation of F. verticillioides

Genomic DNA of F. verticillioides was prepared as
described previously [31]. ImmobilonTM–NY+ Transfer Membrane (Millipore, Bedford, MA) was used for
blot analysis. Southern hybridization was performed using DIG DNA Labeling and Detection Kit (Roche, Indianapolis, IN) according to the manufacturer’s manual. Ten
micrograms of genomic DNA was used in the hybridizations. Two 1.2 kb probes (mt1 and mt2, Fig. 2) were amplified by PCR using primers MT1-MT2 and MT3-MT4
(Table 1), respectively, with Cos6B as template.

The protocol used to isolate and transform protoplasts
was similar to that described by Salch and Beremand
[30] with the following modifications. Conidia were germinated in flask containing 30 ml liquid YPD medium
on a 120 rpm rotary shaker at 30°C for approximately
7–8 h. The conidia were collected and digested at 30°C
for 30–60 min in 20 ml of 0.7 M NaCl containing 5 mg/
ml Novozyme (Sigma), 25 mg/ml driselase (Sigma), and
0.5 mg/ml chitinase (Sigma). For transformation, 5 μg of
plasmid DNA was diluted with an equal volume of 2×
STC buffer to 100 μl and mixed with 100 μl protoplasts,
and transformation was mediated with PEG 8000 buffer (30% PEG 8000; 10 mM Tris–HCl, pH 8.0; 50 mM
CaCl2). The protoplast–DNA mixture was added to 4.5
ml molten regeneration medium and dispensed onto the
surface of 20 ml solidified regeneration medium. After
an overnight incubation, this regeneration medium was
overlaid with 10 ml of 1% water agar supplemented with
525 μg/ml hygromycin B (Calbiochem, La Jolla, CA),
making the final concentration of hygromycin B to 150
μg/ml. Hygromycin-resistant colonies appeared on the
plates in approximately 7 days of incubation at 28°C.
2.4 Screening of F. verticillioides mutants
The screening of mutants involves two stages. The first
stage is to select for gene disruption mutants resulted from
a single crossover of the homologous regions. The hygromycin-resistant colonies on YPD plates were transferred
to a 2 ml YPD liquid medium supplemented with 300 μg/
ml of hygromycin B for further selection. Single conidia were isolated from the surviving colonies, and the culture grown from the conidia were subjected to PCR and

2.5 Southern hybridization

2.6 Co-culture of mutants and analysis of metabolites
The procedure for co-culturing the MT mutant with
FUM6 mutant is identical to that described previously
[32]. FUM6 is a F. verticillioides mutant generated by replacing part (1.5 kb) of the coding region of FUM6 gene
with the hygromycin resistance gene (Hyg B) [33]. For
metabolite production and analysis, the single-conidia derived strains were inoculated in 25 g CMK medium and allowed to grow at 25°C in dark for 3–4 weeks
as described previously [32]. The CMK cultures were
extracted with water/acetonitrile (1:1, v:v). The extracts
were filtered and subjected to HPLC-ELSD (high performance liquid chromatography-evaporative light scattering detection) or LC-ESMS (liquid chromatographyelectrospray mass spectrometry) analysis using the same
procedures described previously [32].
3 Results and discussion
3.1 Development of the screening procedure for mutants
Our goal was to specifically change the active site of
a PKS domain so that a fungal strain with a non-func-
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tional PKS domain would be generated. In order to
reach this goal, the first thing was to develop a relatively efficient and reliable screening procedure suitable for
this filamentous fungus. Both positive (the first stage)
and negative (the second stage) screenings are required
in order to identify the mutant. Therefore, the one-stage
protocol developed previously [23] to screen resistant
colonies will not be appropriate for our purpose. In the
first stage screening, approximately 3–7 hygromycin-resistant colonies were obtained in a typical transformation using 5 μg of plasmid DNA and 107 protoplasts. The
colonies resulted from plasmid DNA integration into the
fungal genome. PCR was used to identify those resulted
from a homologous recombination. The primers LMT1–
LMT2 and RMT1–RMT2 (Table 1) were used to detect
the mutants with a crossover at the upstream (Fig. 2B)
and the downstream (Fig. 2C), respectively, homologous
regions. The engineered Hin dIII site in the mutated MT
domain was used to distinguish the mutants from the
wild-type. Using this selection approach, we obtained
four mutants, mt-7, mt-21, mt-42, and mt-52, from 70
hygromycin-resistant colonies. Mutant mt-42 gave a 1,
473-bp PCR product when the first pair of primers was
used (data not shown). The product was digested by Hin
dIII to give two fragments of 204 and 1269-bp, indicating a homologous recombinant resulting from a crossover at the upstream homologous region (Fig. 2B). In
contrast, the PCR products from the wild type or those
resulted from random insertions were not digestible by
the enzyme although the products were the same size
(data not shown). Mutant mt-7, mt-21, and mt-52 gave
a 1, 689-bp PCR product when the second pair of primers was used. A digestion of the product by Hin dIII
gave two DNA fragments with the expected size of 376
and 1, 313-bp (data not shown), indicating a crossover
at the downstream homologous region. After the single
crossover mutants were confirmed, they were grown on
YPD medium without hygromycin B to select for a second homologous recombination, which will generate either the MT point mutant or reversed mutant (the wild
type). Among 1, 880 single colonies that were derived
from four gene-disrupted mutants, 32 lost hygromycin B
resistance. Among them, 14 were identified as MT point
mutants by PCR and Southern analysis, and the rest
were reversed mutants. Two representative Southern hybridization results are shown in Fig. 2E and F. When the
genomic DNA of the mutants was digested with Hin dIII
and hybridized with mt1 and mt2 probe, the MT point
mutants exhibited 1.3 and 2.1 kb signals, respectively,
while the wild type gave a 3.4 kb signal when hybridized with either of the probes (Fig. 2). Thus, the mutants
contain a point mutation at the active site of the MT domain of FUM1 in F. verticillioides.
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3.2 Metabolite analysis in MT mutants
The fourteen MT point mutants and the 4 gene disruption mutants (mt-7, mt-21, mt-42, and mt-52) were inoculated in CMK medium for 3 weeks for the metabolite analysis. The wild-type strain produced a characteristic pattern
of fumonisins. FB1 was the predominant metabolite with a
[M + H]+ of m/z 722.8 (Fig. 3A and B), whereas FB3 and
FB2 were two minor peaks with the same [M + H]+ of m/z
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706.9 (Fig. 3A and C). As expected, the 4 gene disruption
mutants did not produce any fumonisins (data not shown).
In the point mutants, no fumonisin was detected, whereas
approximately 4 unknown peaks appeared on LC-MS. One
of them gave a [M + H]+ of m/z 679.8, which was most
close to that of demethylated FB3 or FB2. However, extensive MS–MS analyses showed that none of the compounds
had the linear carbon skeleton of fumonisins. Therefore, no
detectable amount of fumonisins or the demethylated analogs was produced in the point mutants. Two possibilities exist for the result. One is that the point mutation at
the MT active site resulted in an inactive Fum1p. Another possibility is that the putative demethylated intermediate (stearyl) that was assembled by the point-mutated
Fum1p was not recognized by downstream enzymes, such
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as Fum8p and Fum6p, in the pathway (Fig. 4). Alternatively, the C18-intermediate could be a substrate for fatty acid
metabolic pathways, such as the β-oxidation. Intermediates
derailed into other pathways are not uncommon in fungal
polyketide biosynthesis [34]. This is possible especially
when the mutants were allowed to grow a prolonged period of time. In order to test if the point-mutated Fum1p was
active, we adopted the co-culture approach. This approach
enables two different FUM mutant strains to functionally
complement each other, so that the final metabolites, which
are much more stable and easier for detection, could be
produced [32]. When the MT point mutant of FUM1 was
co-cultured with the FUM6-deleted mutant [33], FB1 was
clearly produced in the culture (data not shown). The fact
that the fumonisin production was restored in the co-cultures indicated that downstream enzymes were functional
in the MT point mutant because it was able to convert the
intermediates produced by the FUM6 mutant to the final
product. As reported previously [32, 33], the culture of the
FUM6 mutant alone did not accumulate any detectable intermediates when it was allowed to grow for 2–4 weeks.
Several small peaks were observed on LC-MS from the
culture of the FUM6 mutant that was 3–7 days old (Fig.
3D). These peaks eventually disappeared if the culture
was allowed to grow longer, as observed previously [32].
To gain more information, we analyzed the metabolites
in the co-cultures 3–7 days after inoculation. Our previous
experience with these mutants showed that intermediates
were accumulated only at the early stage of the cultures
[32]. Similar to those observed when the deletion mutants
of FUM1 and FUM6 were co-cultured [32], the 3 to 7-day
old co-cultures of MT mutant and FUM6 mutant produced
the normal (methylated) intermediates. For example, the
peak with a [M + H]+ of m/z 340.3 was predicted for the 3keto intermediate (Figs. 3E and G and 4), whereas the peak
with a [M + H]+ of m/z 390.4 for a tetrahydroxylated intermediate (Fig. 3E and H) [32]. In addition to these previously observed peaks, the co-cultures also contained several
peaks with mass corresponding to demethylated intermediates. For example, the peak with a [M + H]+ of m/z 312.3
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is corresponding to the demethylated 3-keto intermediate
(Figs. 3E and F and 4), and the peak with a [M + H]+ of m/
z 330.3 to the demethylated dihydroxy intermediate (Fig.
3E and I). The yield of these intermediates in the mutants
was extremely low and eventually disappeared in the older
cultures. Nevertheless, the results suggest that FUM1 with
a MT point mutation was functional. The results also suggest that the putative demethylated C18 intermediate produced in the MT mutant might be further metabolized by
other pathways. Interestingly, the demethylated intermediates were not observed when the MT mutant was cultured
alone. The reason for this result is not clear, but might be
related to the inability of the culture to produce the more
stable, normal (methylated) intermediates of fumonisin, as
expected when co-cultured with FUM6 mutant [32].
In bacteria, the genetic manipulation of PKS domains
has proven a powerful way to elucidating the domain structure and function of PKSs [1, 8]. Recently, this approach
also has been successfully used in the studies of aromatic fungal polyketides [15, 21]. However, this type of genetic manipulations has not been conducted in reduced fungal
polyketides due to inherent difficulties in detecting the metabolites and the lack of an efficient genetic system for the
filamentous fungi. In this work, we have developed a genetic system through point mutating the active site of the MT
domain of FUM1 in F. verticillioides. This system should
be useful in studies of the biosynthetic mechanism of fumonisins as well as other similar fungal polyketides, implied by the large number of PKSs discovered in genome
sequencing projects of filamentous fungi.
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